Mimmack Michael L, Brooking Justin, Bahn Sabine
Department of Neurobiology, The Babraham Institute, Babraham, Cambridge CB2 4AT, United Kingdom.
Biol Psychiatry. 2004 Feb 15;55(4):337-45. doi: 10.1016/j.biopsych.2003.09.007.
Quantitative polymerase chain reaction (Q-PCR) is now considered the "technique of choice" for validating gene expression changes identified with ribonucleic acid-based expression profiling technologies (especially micro- and macroarray techniques). The identification of altered gene expression profiles with microarrays is best viewed as the first step in the determination of potential disease-associated genes; however, the false-positive rate can be high, particularly with small sample sets and in view of the typically small differences observed in brain expression studies. Quantitative PCR is a rapid and highly sensitive technique for accurate quantification of microarray results; however, careful consideration of experimental design, quality of primer/probe design, internal standards, and normalization procedures are pivotal, particularly when the work involves postmortem tissue.
定量聚合酶链反应(Q-PCR)现在被认为是验证通过基于核糖核酸的表达谱技术(尤其是微阵列和宏阵列技术)所识别的基因表达变化的“首选技术”。利用微阵列识别改变的基因表达谱,最好被视为确定潜在疾病相关基因的第一步;然而,假阳性率可能很高,特别是对于小样本集,并且鉴于在脑表达研究中观察到的差异通常较小。定量PCR是一种用于精确量化微阵列结果的快速且高度灵敏的技术;然而,仔细考虑实验设计、引物/探针设计质量、内标和标准化程序至关重要,尤其是当研究涉及尸检组织时。